King’s College London (KCL) is one of the top UK universities ranked 36th in the world (Times Higher Education World Rankings 2025). KCL has over 42,000 students from some 190 countries, and over 8,500 employees. It is in the top seven UK universities for research earnings and has an overall annual income of about £1.2BN (2024). KCL was ranked 12th in the world for Clinical, Pre-Clinical & Health in the Times Higher Rankings for 2025. 

 

The Faculty of Life Sciences & Medicine (FoLSM), one of the largest and most successful centres for biomedical research and education in the UK. FoLSM is located on four sites – Guy’s, St Thomas’, Waterloo and Denmark Hill on the King’s College Hospital site – reflecting our strong partnership with clinical centres of excellence.  

 

 King’s Comprehensive Cancer Centre (CCC), led by Professor Sheila Singh, is the academic arm of one of the leading cancer centres in Europe. Research at the CCC has a strong and broad base of funding, including strategic investments such as the King’s partnership in the Cancer Research UK City of London Centre (CRUK CoL), CRUK RadNet, the KHP Experimental Cancer Medicine Centre (ECMC) and Breast Cancer Now Research Unit.

 

The Department of Haematology of the CCC is based in the Denmark Hill campus and comprises 10 research groups led by King’s academics, including several clinicians. Research in the Department includes Leukaemia & Myeloma, Lymphoma, Bone Marrow Failure & Myelodysplastic Syndromes, Clonal Haematopoiesis, Allogeneic Stem Cell Transplantation, Molecular Haematology, Sickle Cell Disease and Venous Thrombosis and is supported by flow cytometry and single cell core facilities and the Haematology Biobank.

King’s College London is committed to equality, diversity and inclusion and through this appointment process it is the university’s clear stated aim to develop candidate pools that include applicants from all backgrounds and communities. We particularly encourage applications from women, people from black and minority ethnic communities, the LGBT+ community and from disabled people.

 

Selection process 

Applications will be shortlisted by a selection committee drawn from across the Faculty and NHS partners. Shortlisted candidates will be invited to a two-stage interview process and stakeholder engagement. The final interview panel will be chaired by the Senior Vice President (Health).

 

About The Role

 

We wish to appoint an outstanding individual as Professor in Haematology and Head of the Department of Haematology within the Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences. We are especially interested in individuals with an academic track record and interest in either haemato-oncology, stem cell transplantation, advanced therapies (either oncological or non-oncological) or patient stratification. In addition to pursuing their own state-of-the-art research programme, the postholder will provide strategic leadership for academic haematology including research, education and mentorship of early career clinical and non-clinical scientists.

 

The role as Head of Department is normally held for five years and is renewable for a further five-year term. It would be possible to consider a phased move into the academic leadership role for individuals who would like to first take some time to establish their research programme at King’s.

 

The post will be based predominantly on the  Denmark Hill campus but will interact closely with colleagues across other King’s Health Partners campuses. We would also encourage potential clinician-researcher candidates with a substantial track record in clinical translational research, to contact us to discuss the post.

 

This is a full-time post and you will be offered an indefinite contract.

 

For more detailed information around the responsibilities of the Head of Department, please contact sheila.singh@kcl.ac.uk